Immediate and Sustained Trends in Glycemic Control during Remote Patient Monitoring in People with Type 2 Diabetes. A study investigated whether people with type 2 diabetes (PWT2D) demonstrate improved glycemia after enrolling in remote patient monitoring (RPM) pilot programs that incorporated remote data syncing and coaching. Glycemic improvements were seen within 3 months of program participation and were sustained with continued engagement. The findings indicate that RPM programs that incorporate remote data sharing and coaching can make a substantial impact on glycemic control for people with type 2 diabetes.
Abstract:
Technologies that let patients share diabetes data with care teams can help care teams identify patients with deteriorating glycemic control and facilitate timely and remote-based interventions outside of routine clinic visits. In the current study, we investigated whether people with type 2 diabetes (PWT2D) demonstrate improved glycemia after enrolling in remote patient monitoring (RPM) pilot programs that incorporated remote data syncing and coaching. All program participants were instructed to sync their blood glucose meters with either a mobile app or a computer-based software regularly during program participation. Synced blood glucose data were available to the RPM teams via a web-based dashboard, and remote coaching was administered either regularly and/or as needed. Data from 384 PWT2D (42% female; median age: 50 years) were included in cross-sectional comparisons at baseline and at 3, 6, and 12 months of RPM program participation. Overall trends of immediate (i.e., at 3 months) and sustained (at 6 and 12 months) improvements were observed for mean blood glucose levels (baseline: 178 mg/dL to ~155 mg/dL at 3, 6, 12 months; all Ps <.05), and mean proportion of in-range (70-180 mg/dL; baseline: 60% to ~74% at 3, 6, 12 months; all Ps <.05) and high SMBG readings (>250 mg/dL; baseline: 14% to ~8% at 3, 6, 12 months; all Ps <.05), with no differences in the proportion of low (<70 mg/dL) readings.
https://diabetes.diabetesjournals.org/content/70/Supplement_1/467-P.abstract